Vigabatrin serum concentration to dosage ratio: Influence of age and associated antiepileptic drags

Therapeutic Drug Monitoring

Volumn 19, Issue 5, 1997, Pages 491-498

  Armijo, Juan A ^a,b   Cuadrado, Antonio ^a   Bravo, Jesús ^a   Arteaga, Rosa ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Age influence; Anticonvulsants; Concentration dosage ratio; Drug interactions; Epilepsy; Vigabatrin

Indexed keywords

CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CHILD; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MONITORING; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG INTERACTIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; HUMANS; INFANT; MIDDLE AGED; RETROSPECTIVE STUDIES; VIGABATRIN;

EID: 0031430741     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199710000-00001     Document Type: Article

References (21)

1. Pippenger CE. Pediatric clinical pharmacology of antiepileptic drugs: a special consideration. In: Pippenger CE, Penry JK, Kutt H, eds. Antiepileptic drugs: quantitative analysis and interpretation. New York: Raven, 1978:315-9.
2. Rossi L, Nino L, Principi N. Correlation between age and plasma level/dosage ratio for phenobarbital in infants and children. Acta Pediatr Scand 1979;68:431-4.
3. Battino D, Avanzini G, Bossi L, et al. Plasma levels of primidone and its metabolite phenobarbital: effects of age and associated therapy. Ther Drug Monit 1983;6:73-9.
4. Cloyd J, Kriel R, Fischer J, et al. Pharmacokinetics of valproic acid in children I. Multiple antiepileptic drug therapy. Neurology 1983; 32:185-91.
5. Armijo JA, Herranz JL, Valiente R, et al. Concentration-dose relationship of antiepileptic drugs in pediatric outpatients during monotherapy: interindividual variability and influence of age. Rev Farmacol Clin Exp 1989;6:83-8.
6. Yukawa E, Suzuki A, Higuchi S, et al. Influence of age and concurrent medication on steady-state valproic acid serum level-dose ratios in Japanese paediatric patients. J Clin Pharm Ther 1991;16: 291-7.
7. Yukawa E, Suzuki A, Higuchi S, et al. Influence of age and comedication on steady-state carbamazepine serum level-dose ratios in Japanese paediatric patients. J Clin Pharm Ther 1992;17:65-9.
8. Yukawa E, Higuchi S, Aoyama T. Influence of age and comedication on steady-state phenobarbital serum level-dose ratios in Japanese paediatric patients. J Clin Pharm Ther 1992;17:249-53.
9. Grant SM, Heel RC. Vigabatrin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs 1991;41(6):889-926.
10. Rey E, Pons G, Olive G. Vigabatrin: clinical pharmacokinetics. Clin Pharmacokinet 1992;23:267-78.
11. Haegele KD, Huebert ND, Ebel M, et al. Pharmacokinetics of vigabatrin: implications of creatinine clearance. Clin Pharmacol Ther 1988;44:558-65.
12. Rey E, Pons G, Richard MO, et al. Pharmacokinetics of the individual enantiomers of vigabatrin (γ-vinyl GABA) in epileptic children. Br J Clin Pharmacol 1990;30:253-7.
13. Patsalos PN, Duncan JS. New antiepileptic drugs. CNS Drugs 1994;2:40-77.
14. Reidenberg P, Glue P, Banfield C, et al. Pharmacokinetic interaction studies between felbamate and vigabatrin. Br J Clin Pharmacol 1995;40:157-60.
15. Armijo JA, Arteaga R, Valdizán EM, et al. Coadministration of vigabatrin and valproate in children with refractory epilepsy. Clin Neuropharmacol 1992;15:459-69.
16. Eslami M, Stuart JD, Dean RW. Analysis of taurine in blood plasma of epileptic patients using an improved isocratic HPLC method for amino acids. J Liquid Chromatogr 1987;10:977-97.
17. Valdizán EM, Armijo JA. Relationship between platelet and brain GABA transaminase inhibition by single and multiple doses of vigabatrin in rats. Epilepsia 1991;32:735-42.
18. Gram L, Lyon BB, Dam M. Gamma-vinyl GABA: a single-blind trial in patients with epilepsy. Acta Neurol Scand 1983;60:34-9.
19. Browne TR, Mattson RH, Penry JK, et al. Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-up. Neurology 1987;37:184-9
20. Sivenius MRJ, Ylinen A, Murros K, et al. Double-blind dose reduction study of vigabatrin in complex partial epilepsy. Epilepsia 1987;28:688-92.
21. Arteaga R, Herranz JL, Valdizán EM, Armijo JA. γ-Vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children. Epilepsia 1992;33(5):923-31.